Page 2 - வெளிப்படையான ழோ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வெளிப்படையான ழோ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வெளிப்படையான ழோ Today - Breaking & Trending Today

China Jo-Jo Drugstores Completes Redomiciliation Merger

China Jo-Jo Drugstores Completes Redomiciliation Merger
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Cayman Islands , Frank Zhao , Tina Xiao , Exchange Commission , Prnewswire China Jo Drugstores Inc , Company Contact , China Jo Drugstores Inc , Ascent Investor Relations , Jo Drugstores , Redomiciliation Merger , China Jo Drugstores , Relations Contact , கேமன் தீவுகள் , வெளிப்படையான ழோ , டினா கிஷியஓ , பரிமாற்றம் தரகு , நிறுவனம் தொடர்பு , ஏற்றம் முதலீட்டாளர் உறவுகள் , உறவுகள் தொடர்பு ,

China Jo-Jo Drugstores Hosts Reception for Provincial Government Officials

Share this article
Share this article
HANGZHOU, China, May 6, 2021 /PRNewswire/ China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ( Jo-Jo Drugstores or the Company ), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the Company hosted a reception on April 26, 2021 for provincial government officials including Ms. Huili Qi, deputy director of Shaanxi Medical Products Administration ( SMPA ), Mr. Yangyi Zhan, head of SMPA s Circulation and Development Department, Mr. Zhiliang Su, deputy director of Zhejiang Medical Products Administration ( ZMPA ), and Ms. Wang Bei, deputy head of ZMPA s Medical Products Circulation Department. ....

Frank Zhao , Huili Qi , Yangyi Zhan , Zhiliang Su , Tina Xiao , Shaanxi Medical Products Administration , Zhejiang Medical Products Administration , Products Circulation Department , Company Contact , China Jo Drugstores Inc , Exchange Commission , Prnewswire China Jo Drugstores Inc , Development Department , Ascent Investor Relations , Jo Drugstores , Wang Bei , Good Supply Practice , Zhejiang Province , Lei Liu , China Jo Drugstores , Relations Contact , வெளிப்படையான ழோ , டினா கிஷியஓ , நிறுவனம் தொடர்பு , பரிமாற்றம் தரகு , வளர்ச்சி துறை ,

China Jo-Jo Drugstores Releases 2020 Letter from the Chairman

Share this article
Share this article
HANGZHOU, China, Feb. 2, 2021 /PRNewswire/ China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ( Jo-Jo Drugstores or the Company ), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products, and healthcare provider in China, released a letter to shareholders from the Chairman of the Company s board of directors today.
Dear shareholders,
The 2020 COVID-19 pandemic has brought unexpected challenges to everyone. It also brought tremendous impact and pressure to the development of enterprises. During this period, we made every effort to guarantee sufficient medicine supply, build a pandemic medicine center and provide online pharmacy consultation services. We used our expertise to fight against the pandemic. ....

Frank Zhao , Steve Liu , Tina Xiao , Drugstores Inc , Company Contact , Company Binjiang , Hangzhou Municipal Medical Insurance Bureau , Chinese Pharmaceutical Retail Company , National Health New Retailers , Company Binjiang District , Ascent Investor Relations , During The Company , Information Bureau , China Jo Drugstores Inc , Zhejiang Colorful Sunshine Charity Foundation , Exchange Commission , Health Ambassador Selection Competition , China Growth Pharmaceutical Enterprise Development Forum , Rapid Development , New Page , Yingda Insurance , Jo Drugstores , Zhejiang Provincial Government , Zhejiang Colorful Sunshine Charity , Changzhou Economic , Binjiang District ,

China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement

Share this article
Share this article
HANGZHOU, China, Dec. 23, 2020 /PRNewswire/ China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ( Jo-Jo Drugstores or the Company ), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has received notification from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which concerns minimum bid price listing requirements.
As previously disclosed, on October 16, 2020, Nasdaq notified the Company that its common stock had failed to maintain a minimum bid price of $1.00 over 30 consecutive business days as required by the Nasdaq Listing Rules. ....

Frank Zhao , Steve Liu , Tina Xiao , Drugstores Inc , Company Contact , China Jo Drugstores Inc , Exchange Commission , Listing Qualifications Department , Prnewswire China Jo Drugstores Inc , Ascent Investor Relations , Jo Drugstores , Nasdaq Stock Market , Nasdaq Listing Rule , Nasdaq Listing , Listing Rule , China Jo Drugstores , Relations Contact , வெளிப்படையான ழோ , ஸ்டீவ் லியூ , டினா கிஷியஓ , நிறுவனம் தொடர்பு , பரிமாற்றம் தரகு , பட்டியல் தகுதிகள் துறை , ஏற்றம் முதலீட்டாளர் உறவுகள் , நாஸ்டாக் ஸ்டாக் சந்தை , நாஸ்டாக் பட்டியல் ஆட்சி ,

Uni-Bio Science Group: The National Medical Products Administration Granted Marketing Approval for BOSHUTAI® (Acarbose Tablets) in China

®. Next step, the Company will focus on the launch and successful commercialization of BOSHUTAI
®. As manufacturing cost leadership is essential for the success of the product, the company is already working with a number of strategic partnerships across the supply chain to ensure BOSHUTAI
® is manufactured at the lowest cost possible. Additionally, the Company successfully held the BOSHUTAI
® launch conference on 11 December 2020, where more than 60 commercial partners attended the event.
Acarbose was first developed by Bayer in 1975 and launched in Switzerland in 1986 (trade name: Glucobay
®). As the first FDA-approved alpha-glucosidase inhibitor in the world, it entered China in 1994 and is now recommended as a first-line drug for T2D. Acarbose is sold far better in China and Asia than in other western countries due to the high carbohydrate content in Asian cuisine. ....

Frank Zhao , Xu Honglei , Bio Science Group , Science Group Head , National Essential Medicine List , National Basic Medical Insurance , China National Drug Centralized Procurement Scheme , National Medical Products Administration , Science Group , International Diabetes Federation , Bio Science Group Limited The Company , Bio Science Group Limited , Acarbose Tablets , Yingli Executive Director , Acarbose Market Authorization Holder , Uni Bio Science Group , China Diabetes Prevention , Therapy Guide , National Basic Medical , வெளிப்படையான ழோ , உயிர் அறிவியல் குழு , அறிவியல் குழு தலை , தேசிய அவசியம் மருந்து பட்டியல் , தேசிய அடிப்படை மருத்துவ காப்பீடு , சீனா தேசிய மருந்து மையப்படுத்தப்பட்ட ப்ரொக்யூர்மெஂட் திட்டம் , அறிவியல் குழு ,